The Trump administration wanted acting FDA Commissioner Kyle Diamantas to accept the job permanently. He declined, so they ...
Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout ...
Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has ...
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping ...
Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for ...
Washington has rediscovered faith as a delivery mechanism. The bigger opportunity is faith as a source of capital,” writes Dr ...
Heidi Overton's rise under Trump, inside a 5-year-old brain organoid, and other health news from Morning Rounds ...
Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Males make up about a third of the population struggling with eating disorders in the United States. While these conditions ...
Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several ...
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful ...
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results